A review of nanofiber-based drug delivery systems: fabrication, characterization, advances, and future prospects

Обзор систем доставки лекарств на основе нанофибров: изготовление, характеристика, достижения и перспективы
A. M. Saleh, Ahmed M. Saleh, Radwa N. Selim, Manar T El-Morsy, Shereen A. Mansour, Reem H Elhady, Shaimaa F. K. Ismail, Mostafa Gamal, El-Refaie S. Kenawy
2026-03-27

3D bioprinting and AI-driven personalizationbiocompatibilitybioresponsive smart nanofiberselectrospinningnanofiber-based drug delivery systems
Nanofibers have emerged as advanced drug delivery systems due to their large surface area, adjustable porosity, and ability to facilitate controlled and sustained drug release. This Review thoroughly analyzes the synthesis processes of nanofibers, including electrospinning, self-assembly, Phase separation, Printing method, and template-assisted approaches, emphasizing their advantages and disadvantages. The importance of material selection is explored, highlighting the role of synthetic, natural, and composite polymers in enhancing nanofiber efficacy for biomedical applications. Key challenges like scalability, biocompatibility, In Vivo applicability, and recent developments in hybrid and biomimetic nanofibers are discussed. This study investigates recent advancements in the therapeutic application of nanofiber-based drug delivery systems, concentrating on their vivo efficacy and safety profiles. We emphasize novel tactics that combine artificial intelligence (AI) and 3D bioprinting to facilitate individualized treatment solutions customized for particular patient requirements. The assessment delineates promising future approaches, encompassing the advancement of bioresponsive and "smart" nanofiber systems, implantable and in situ-forming platforms, and advances focused on scalable, sustainable manufacturing. These insights combined offer a prospective view on the advancement of nanofiber technology from laboratory to clinical application. Graphical abstract
1
Key challenges identified include scalability, biocompatibility, and in vivo applicability, limiting translation from lab to clinic.
2
Material selection (synthetic, natural, composite polymers) critically influences nanofiber efficacy for biomedical applications.
3
Nanofibers are promising drug delivery systems due to large surface area, tunable porosity, and controlled sustained drug release capability.
4
Recent advances include hybrid and biomimetic nanofibers, AI-integrated design, and 3D bioprinting for personalized therapies, plus development of bioresponsive/smart, implantable, and in situ-forming platforms.
5
The Review analyzes multiple fabrication methods — electrospinning, self-assembly, phase separation, printing, and template-assisted — detailing their respective advantages and disadvantages.

Nanofiber-based drug delivery systems

Fabrication methods, material selection, characterization, therapeutic efficacy and safety in vivo, scalability and biocompatibility challenges, and future smart/bioresponsive and implantable nanofiber platforms including AI and 3D bioprinting-enabled personalized treatments

Publication Details
Publication Date
2026-03-27
Journal
Publisher
ISSN
Cited by
7
Access Type
Author Information
Authors
A. M. Saleh
Ahmed M. Saleh
Radwa N. Selim
Manar T El-Morsy
Shereen A. Mansour
Reem H Elhady
Shaimaa F. K. Ismail
Mostafa Gamal
El-Refaie S. Kenawy
Explore further
Open the scid.ai AI chat with a ready-made request: it will find papers on a similar topic and help build a literature review.
Find similar papers in the chat
Make a presentation
100%